Page 3 - Les meilleurs doctors traitant la maladie suivante : Adénocarcinome sigmoïde - TOP -95 des médecins

Professeur agrégé depuis 2016, le Dr Ozatli apporte une rigueur académique au traitement des cancers gastro-intestinaux à l'hôpital Liv de l'université Istinye, Bahcesehir.

• Se spécialiser dans les cancers du sein, du poumon et gastro-intestinaux
• Être spécialiste en médecine interne avec une expérience dans plusieurs hôpitaux
• Pratiquer l'oncologie à la clinique d'oncologie d'Ankara et à l'hôpital régional de formation d'Erzurum
• Être formé à la faculté de médecine de l'université de Selcuk

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Le professeur associé Nail Paksoy se spécialise en oncologie médicale à l'hôpital Medipol Bahcelievler, avec un accent particulier sur les cancers gastro-intestinaux.

• Certifié par l'ESMO en oncologie médicale
• Participation à des essais cliniques internationaux pour les traitements du cancer colorectal
• Recherche publiée sur le protocole FLOT pour le cancer gastrique métastatique

Le Dr Mustafa Serkan Alemdar est un spécialiste en oncologie médicale doté d'une solide formation académique et d'une vaste expérience hospitalière.

• Formé à l'Université d'Akdeniz – l'une des principales facultés de médecine de Turquie
• Se spécialiser en médecine interne et en oncologie médicale
• Des années d'expérience dans plusieurs hôpitaux prestigieux
• Se concentrer sur les soins et le traitement complets du cancer

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Spécialisé en chirurgie laparoscopique pour l'adénocarcinome sigmoïde – formé dans les meilleurs programmes de l'Université d'Istanbul.

• Plus de 20 ans d'expérience chirurgicale
• Formation avancée en chirurgie laparoscopique bariatrique et oncologique
• Réaliser des procédures mini-invasives pour une meilleure récupération

Le Dr Alon Pikarsky enseigne et forme de nouveaux chirurgiens depuis plus de 20 ans au sein du service de renommée mondiale du centre médical Hadassah.

• Maître de conférences en chirurgie depuis 2005
• Directeur du programme de résidence depuis 2000 – formation des futurs chirurgiens
• Certifié en chirurgie générale avec une surspécialisation en chirurgie colorectale
• Certifié par le conseil israélien en chirurgie générale depuis 1998
• Membre de longue date de multiples associations chirurgicales professionnelles

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Plus de 30 ans d'expérience en immunologie avec une spécialisation en virothérapie – Le Dr Jaunalksne dirige le centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins.

• Se spécialiser dans l'un des domaines les plus récents de l'immunologie
• Être diplômée de l'Institut de médecine de Riga
• Effectuer un internat en médecine interne
• Diriger le centre d'immunologie clinique

Spécialisé en chirurgie oncologique, particulièrement le cancer du côlon, avec une concentration sur les cas complexes aux hôpitaux Büyük Anadolu.

• Expert en chirurgie du pancréas et des voies biliaires
• Réalisation de chirurgies bariatriques et métaboliques avancées
• Compétent dans les interventions pour le cancer du sein et de la thyroïde

Plus de 15 000 interventions chirurgicales pratiquées – Le Dr de Lacy est un pionnier des techniques mini-invasives pour le cancer du côlon et du rectum à l'Hôpital Quiron Barcelone.

• Réaliser plus de 1 000 interventions par an en utilisant la chirurgie laparoscopique et robotique
• Être le premier au monde à réaliser la technique TaTME pour le cancer du rectum
• Être Président de l'Association des chirurgiens-endoscopistes d'Europe
• Donner des conférences internationales sur les techniques de laparoscopie avancée

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Le Dr Alexander Beny dirige le service des tumeurs malignes gastro-intestinales et utilise une approche hautement ciblée combinant l'oncologie médicale et la radiothérapie.

• Plus de 30 ans d'expérience au centre médical Rambam
• Diriger les cliniques de gastro-entérologie et d'onco-gynécologie
• Certifié par les conseils médicaux israélien et européen
• Avoir suivi une formation spécialisée en curiethérapie auprès de l'ESTRO
• Titulaire d'un doctorat en médecine de la faculté de médecine de Florence en Italie

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Le Prof. Thomas W Kraus a réalisé plus de 3 000 interventions chirurgicales pour des maladies intestinales, se spécialisant dans les cas complexes d'oncologie gastro-intestinale à la Clinique Nordwest.

• Expert reconnu au niveau national en chirurgie pancréatique et hépatobiliaire
• Fondateur et directeur de la société allemande « Art of Surgery »
• Utiliser des techniques mini-invasives telles que la sonographie peropératoire
• Formé dans les meilleurs centres de cancérologie, notamment Johns Hopkins et Memorial Sloan-Kettering
• Lauréat de multiples prix internationaux pour l'excellence chirurgicale

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.